BDBM296020 3-[(2R)-4-hydroxy-1-[3- methoxy-4-(1H-pyrazol- 4-yl)benzoyl]pyrrolidin- 2-yl]-N-[(5-methyl-1,2- oxazol-3-yl)methyl] benzamide::US10112939, Example 59

SMILES COc1cc(ccc1-c1cn[nH]c1)C(=O)N1CC(O)C[C@@H]1c1cccc(c1)C(=O)NCc1cc(C)on1

InChI Key InChIKey=CDBFWNRQMZREME-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 296020   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM296020(US10112939, Example 59 | 3-[(2R)-4-hydroxy-1-[3- m...)
Affinity DataIC50: 1.80nMpH: 7.5Assay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2019
Entry Details
US Patent